- Home
- INCR vs MBOT Comparison
INCR vs MBOT Comparison
Compare INCR & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- MBOT
- Stock Information
- Founded
- INCR 1994
- MBOT 2010
- Country
- INCR Israel
- MBOT United States
- Employees
- INCR N/A
- MBOT N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- MBOT Medical/Dental Instruments
- Sector
- INCR Health Care
- MBOT Health Care
- Exchange
- INCR Nasdaq
- MBOT Nasdaq
- Market Cap
- INCR 84.5M
- MBOT 94.6M
- IPO Year
- INCR N/A
- MBOT N/A
- Fundamental
- Price
- INCR $1.51
- MBOT $2.50
- Analyst Decision
- INCR
- MBOT Strong Buy
- Analyst Count
- INCR 0
- MBOT 1
- Target Price
- INCR N/A
- MBOT $9.00
- AVG Volume (30 Days)
- INCR 28.2K
- MBOT 1.1M
- Earning Date
- INCR 08-15-2025
- MBOT 08-13-2025
- Dividend Yield
- INCR N/A
- MBOT N/A
- EPS Growth
- INCR N/A
- MBOT N/A
- EPS
- INCR N/A
- MBOT N/A
- Revenue
- INCR $65,575,323.00
- MBOT N/A
- Revenue This Year
- INCR $69.54
- MBOT N/A
- Revenue Next Year
- INCR $41.75
- MBOT N/A
- P/E Ratio
- INCR N/A
- MBOT N/A
- Revenue Growth
- INCR N/A
- MBOT N/A
- 52 Week Low
- INCR $1.17
- MBOT $0.82
- 52 Week High
- INCR $2.62
- MBOT $3.38
- Technical
- Relative Strength Index (RSI)
- INCR 46.22
- MBOT 49.35
- Support Level
- INCR $1.48
- MBOT $2.39
- Resistance Level
- INCR $1.64
- MBOT $2.59
- Average True Range (ATR)
- INCR 0.05
- MBOT 0.14
- MACD
- INCR -0.00
- MBOT -0.00
- Stochastic Oscillator
- INCR 30.81
- MBOT 31.58
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.